FY2025 · ended Dec 31, 2025 · Revenue $94.57M, -31.8% YoY · Filed Mar 10, 2026
Siga Technologies INC (SIGA) files with the SEC under industry code 2834, Pharmaceutical Preparations. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $94.6 million and net income of $23.3 million. As of Jun 30, 2026 it held $117.6 million in cash and investments and $439,397 in total debt.
Revenue (TTM)
$53.66M
-70.1% vs year-ago TTM
Net income (TTM)
$-2.79M
-103.4% vs year-ago TTM
Operating cash flow (TTM)
$-20.17M
-116.9% vs year-ago TTM
Free cash flow
$-18.23M
-126.5% vs prior year
EPS (TTM)
$-0.04
-103.4% vs year-ago TTM
Dividend per share (TTM)
$0.60
+0.0% vs year-ago TTM
Shares outstanding
71.64M
+0.3% vs prior year
Net cash
$117.15M
as of Jun 30, 2026
Operating margin
-20.8%
FY 2026
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SIGA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 1010086
- Former names
- SIGA PHARMACEUTICALS INC (until May 25, 2000)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $94.6M | $138.7M | $139.9M | $110.8M | $133.7M |
| Operating income | $23.7M | $70.0M | $83.6M | $42.7M | $89.1M |
| Net income | $23.3M | $59.2M | $68.1M | $33.9M | $69.5M |
| Diluted EPS | $0.32 | $0.82 | $0.95 | $0.46 | $0.91 |
| Operating cash flow | $43.5M | $48.8M | $94.8M | $41.6M | $11.5M |
| Total assets | $219.5M | $244.3M | $254.4M | $195.0M | $214.7M |
| Total liabilities | $20.6M | $28.5M | $57.5M | $24.9M | $40.4M |
| Stockholders' equity | $198.8M | $215.8M | $196.9M | $170.2M | $174.3M |
| Cash and investments | $155.0M | $155.4M | $150.1M | $98.8M | $103.1M |
| Total debt | $759,207 | $1.4M | — | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
All 1002 Siga Technologies INC SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.